MedPath

Effectiveness of Vonoprazan in patients treated with post-ESD gastric ulcer

Not Applicable
Conditions
gastric neoplasm
Registration Number
JPRN-UMIN000016642
Lead Sponsor
Tsuyama Chuo Hospital
Brief Summary

A total of 168 patients were analyzed. The 4-week healing rate for artificial ulcer was not significantly higher in Vonoprazan group versus group Lansoprazole (17/85, 20.0% vs. 14/83, 16.9%, respectively). In addition, there were no significant differences between the 4-week shrinkage rates between the two groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
168
Inclusion Criteria

Not provided

Exclusion Criteria

Remnant stomach, administration of antithrombotic agents, non-steroidal anti-inflammatory drugs and steroids, occurrence of complication during ESD, allergy to lansoprazole or vonoprazan, and unwillingness to participate in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath